Application of anti-NMDAR autoantibody as congenital megacolon diagnostic marker
A technology for Hirschsprung's disease and autoantibodies, applied in the field of biomedicine, can solve the problems of inconspicuous barium enema, influential results and high price, and achieve the effects of good sensitivity and specificity, simple operation and low cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0079] Example 1. Plasma and tissue sample collection and grouping
[0080] Plasma samples were divided into Hirschsprung's disease children group (37 cases), other enteropathy control group (18 cases), healthy children group (30 cases), the age ranged from 3 months to 3 years old, and the gender was 3 / 4 male. Male, disease and control groups were matched for age and sex. All samples were obtained from Guangzhou Women's and Children's Medical Center, and the healthy children group was the remaining blood samples after physical examination of healthy children. The blood collection method is anticoagulation blood collection, centrifugation to separate plasma, and frozen samples. Colon tissue samples were from the group of children with Hirschsprung's disease (36 cases), which were surgically resected lesions. Other enteropathy control group (including 11 cases of colon tissue with anal stricture and intestinal stricture fistula).
Example Embodiment
[0081] Example 2. Human autoimmune antigen chip screening and differentially expressed autoantibody analysis
[0082] Plasma from 5 children with Hirschsprung's disease (HSCR), 5 from healthy group (HC) and 5 from other enteropathy (DC) groups were used for the screening of human neuroimmune chip, which was developed by Guangzhou Yijin Biotechnology Co., Ltd. Provided by Technology Co., Ltd., including the IgG detection of more than 100 kinds of neural autoimmune antibodies, the original data, after subtracting the negative control, were normalized by the RLM method, and the results were analyzed by M statistics. figure 1 Cluster analysis graph showing differential autoantibodies, from which it can be seen that anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies were significantly higher in plasma from children with Hirschsprung's disease than in controls ( p=0.018).
Example Embodiment
[0083] Example 3. Detection of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies in Hirschsprung's disease tissue
[0084] N-methyl-D-aspartate receptor (NMDAR) is a protein specifically expressed in neural tissue, and autoantibodies to this protein have been reported in encephalitis, but not in peripheral enteric nervous system diseases. In order to verify that the anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies are indeed derived from the enteric nerve tissue of the diseased segment of megacolon patients, the intestinal tissues of the diseased segment of megacolon patients were collected (36 cases), and Colon tissue of other intestinal diseases (including 11 cases of colon tissue with anal stenosis and intestinal stenosis), the anti-N-methyl-D-aspartate receptor (NMDAR) in the tissue was detected by enzyme-linked immunosorbent assay (ELISA). The level of autoantibodies was detected by a human anti-N-methyl-D-aspartate receptor (NMDAR) autoantibody antibody ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap